Crescent Capital BDC Inc
NASDAQ:CCAP
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
16.03
19.98
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Crescent Capital BDC Inc
Wall Street
Price Targets
CCAP Price Targets Summary
Crescent Capital BDC Inc
According to Wall Street analysts, the average 1-year price target for
CCAP
is 20.06 USD
with a low forecast of 18.18 USD and a high forecast of 21 USD.
CCAP Last Price Targets
Crescent Capital BDC Inc
The latest public price target was made on May 13, 2024 by
Finian O'Shea
from
Wells Fargo
,
who expects
CCAP
stock to
drop by 8%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Finian O'Shea
Wells Fargo
|
18
USD
Downside 8% |
7 months ago
May 13, 2024
|
Crescent Capital BDC price target raised to $18 from $16.50 at Wells Fargo
TheFly
|
Robert Dodd
Raymond James
|
19
USD
Downside 3% |
7 months ago
May 10, 2024
|
Crescent Capital BDC price target raised to $19 from $18 at Raymond James
TheFly
|
Operating Income
Forecast
Operating Income Estimate
Crescent Capital BDC Inc
For the last 7 years the
compound annual growth rate for
Crescent Capital BDC Inc's operating income is
44%.
The projected
CAGR
for the next 3 years is
-4%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CCAP's stock price target?
Price Target
20.06
USD
According to Wall Street analysts, the average 1-year price target for
CCAP
is 20.06 USD
with a low forecast of 18.18 USD and a high forecast of 21 USD.
What is Crescent Capital BDC Inc's Revenue forecast?
Projected CAGR
-2%
For the last 7 years the
compound annual growth rate for
Crescent Capital BDC Inc's revenue is
45%.
The projected
CAGR
for the next 3 years is
-2%.
What is Crescent Capital BDC Inc's Operating Income forecast?
Projected CAGR
-4%
For the last 7 years the
compound annual growth rate for
Crescent Capital BDC Inc's operating income is
44%.
The projected
CAGR
for the next 3 years is
-4%.
What is Crescent Capital BDC Inc's Net Income forecast?
Projected CAGR
-6%
For the last 7 years the
compound annual growth rate for
Crescent Capital BDC Inc's net income is
32%.
The projected
CAGR
for the next 3 years is
-6%.
You don't have any saved screeners yet
